Medicare Enrolled
Dr. Michael Tucciarone, M.D.
Cardiovascular Disease · Rochester, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tucciarone from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tucciarone?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tucciarone
Dr. Michael Tucciarone is a cardiovascular disease specialist in Rochester, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Tucciarone performed 3,912 Medicare services across 3,075 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tucciarone received a total of $13,700 from 36 pharmaceutical and/or device companies across 274 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tucciarone is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 10% volume in MI
$13,700 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,912
Medicare services
Top 10% in MI for cardiovascular disease
3,075
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~206 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
846 | $65 | $84 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
799 | $10 | $51 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
697 | $62 | $100 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
300 | $143 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
215 | $97 | $150 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
190 | $48 | $100 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
164 | $108 | $175 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
152 | $149 | $400 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
115 | $7 | $50 |
| Cardiac catheterization | 80 | $205 | $600 |
| Continuous ECG monitoring with transmission and review Continuous electrocardiogram monitoring for up to 30 days with symptom tracking. The data is transmitted and reviewed by a healthcare professional who provides a report. |
53 | $15 | $40 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
45 | $15 | $50 |
| Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | 33 | $573 | $1,200 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
32 | $11 | $100 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
31 | $42 | $67 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
24 | $99 | $125 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
22 | $87 | $225 |
| Continuous ECG monitoring with symptom tracking, up to 30 days This procedure involves continuous electrocardiogram monitoring for up to 30 days. It includes symptom monitoring to correlate heart activity with patient-reported events. |
20 | $7 | $35 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 20 | $285 | $700 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
18 | $81 | $200 |
| Intravascular ultrasound of heart vessel, initial An ultrasound procedure used to evaluate a blood vessel within the heart during a diagnostic or treatment procedure. |
16 | $62 | $200 |
| Transcatheter aortic valve replacement via femoral artery A minimally invasive procedure to replace a diseased aortic heart valve using a catheter inserted through the skin and femoral artery. |
15 | $657 | $2,500 |
| Perflutren lipid microspheres injection Injection of perflutren lipid microspheres, measured per milliliter. |
14 | $34 | $175 |
| Tube insertion in bypass graft for diagnosis A tube is inserted into a bypass graft to allow for diagnostic evaluation. A radiologist reviews the procedure. |
11 | $121 | $500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.4% high complexity
1.2% medium
91.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,700
Total received (2018-2024)
Avg $1,957/year across 7 years
Top 20% in MI for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
274
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,640 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$60 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,051
2023
$1,591
2022
$2,615
2021
$1,087
2020
$139
2019
$2,482
2018
$735
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$2,302
Medtronic, Inc.
$667
ABIOMED
$463
Inari Medical, Inc.
$415
Edwards Lifesciences Corporation
$411
Abbott Laboratories
$130
Merck Sharp & Dohme LLC
$106
Boehringer Ingelheim Pharmaceuticals, Inc.
$90
Kiniksa Pharmaceuticals International, plc
$72
Alnylam Pharmaceuticals Inc.
$62
Amgen Inc.
$60
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$50
Bayer Healthcare Pharmaceuticals Inc.
$44
Novartis Pharmaceuticals Corporation
$39
Actelion Pharmaceuticals US, Inc.
$35
Novo Nordisk Inc
$21
Chiesi USA, Inc.
$19
Janssen Pharmaceuticals, Inc
$18
AstraZeneca Pharmaceuticals LP
$17
CORDIS US CORP.
$17
E.R. Squibb & Sons, L.L.C.
$13
Top 3 companies account for 67.9% of 2024 payments
All-time payments by company (2018-2024) ›
Edwards Lifesciences Corporation
$3,646
Boston Scientific Corporation
$2,714
ABIOMED
$1,496
Abbott Laboratories
$1,138
Inari Medical, Inc.
$964
Cardiovascular Systems Inc.
$884
Medtronic, Inc.
$679
Amgen Inc.
$422
Intact Vascular, Inc.
$175
Imperative Care, Inc
$144
ATRICURE, INC.
$134
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$133
Merck Sharp & Dohme LLC
$106
Medtronic Vascular, Inc.
$91
Boehringer Ingelheim Pharmaceuticals, Inc.
$90
BOSTON SCIENTIFIC CORPORATION
$89
Kiniksa Pharmaceuticals International, plc
$72
Philips Electronics North America Corporation
$67
Janssen Pharmaceuticals, Inc
$63
Alnylam Pharmaceuticals Inc.
$62
Bayer Healthcare Pharmaceuticals Inc.
$61
CORDIS US CORP.
$49
HeartFlow, Inc.
$49
AstraZeneca Pharmaceuticals LP
$42
PFIZER INC.
$41
Chiesi USA, Inc.
$41
Novartis Pharmaceuticals Corporation
$39
Teleflex LLC
$39
Actelion Pharmaceuticals US, Inc.
$35
Shockwave Medical, Inc
$32
CARDIVA MEDICAL, INC.
$21
Novo Nordisk Inc
$21
Siemens Medical Solutions USA, Inc.
$17
Veryan Medical Incorporated
$14
EKOS Corporation
$13
E.R. Squibb & Sons, L.L.C.
$13
Top 3 companies account for 57.3% of all-time payments
Associated products mentioned in payments ›
(6554) Peripheral Vascular Undivided · ABSOLUTE PRO · AMPLATZER AMULET · AMPLATZER Occluders · AMPLATZER TALISMAN · Adempas · AngioJet Ultra 5000A · Arcalyst · Artis icono floor · Asahi Fielder coronary guide wire · BRILINTA · BioMimics 3D Vascular Stent System · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CONFIRM RX · COREVALVE EVOLUT R · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · Diamondback Coronary · Diamondback Peripheral · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · EKOSONIC · ELIQUIS · ELUVIA · EMBLEM · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · EkoSonic · FARXIGA · FFRct · FLOWTRIEVER CATHETER · HeartMate 3 Left Ventricular Assist Device · Hi-Torque Balance guide wires · IGT_D Coronary · Image Guided Therapy Devices _ Coronary · Impella · Interventional Products · JARDIANCE · JETI ALL IN ONE NON-STERILE KIT · JETSTREAM SC · KENGREAL · LANGSTON · LEQVIO · LUX DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · MYNX CONTROL · Mynx Venous VCD · ONPATTRO · OPSUMIT · Optis Coronary Imaging System · PERCLOSE PROGLIDE · Peripheral Orbital Atherectomy System · Quadra Assura CRT Defibrillator · RAIN SHEATH TRANSRADIAL · ROTABLATOR · Repatha · S · SAPIEN 3 Ultra RESILIA · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYMPHONY CATHETER · SYNERGY · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · Tack Endovascular System · VERQUVO · VIGILANT · VYNDAQEL · Varithena Administration Pack · Vascular Lithotripsy · VersaCross Access Solution · WALLSTENT · WATCHMAN Access System · Wegovy · XARELTO · XIENCE SIERRA · Xience Alpine cornary stent system · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System · Xience cornary stent systems
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
281
Per 100K population
22.1
County median income
$95,296
Nearest hospital
ASCENSION PROVIDENCE ROCHESTER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tucciarone is a clinical cardiology specialist, with above-average Medicare volume (top 10% in MI), with low-engagement industry engagement in the top 20% of MI peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tucciarone experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Tucciarone performed 846 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tucciarone receive payments from pharmaceutical companies?
Yes. Dr. Tucciarone received a total of $13,700 from 36 companies across 274 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tucciarone's costs compare to other cardiologists in Rochester?
Dr. Tucciarone's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tucciarone) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Rochester
Browse cardiologists in Rochester ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in MI
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in MI
Which MI cardiologists receive the most from drug and device companies.
By company
Edwards Lifesciences Corporation Payments to Doctors
See all physicians who received payments from Edwards Lifesciences Corporation.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology